Niraparib Monotherapy for Late-Line Treatment of Ovarian Cancer (Quadra): a Multicentre, Open-Label, Single-Arm, Phase 2 Trial

AuthID
 P-00V-T7F
20
Author(s)
Moore K.N.
·
Geller M.A.
·
Cloven N.
·
Fleming G.F.
·
Wahner Hendrickson A.E.
·
DiSilvestro P.
·
Oza A.M.
·
Cristea M.
·
Berek J.S.
·
Chan J.K.
·
Matei D.E.
·
Li Y.
·
Sun K.
·
Matulonis U.A.
·
Document Type
Article
Year published
2019
Published
in The Lancet Oncology, ISSN: 1470-2045
Volume: 20, Issue: 5, Pages: 636-648 (12)
Indexing
Scopus®
Crossref®346
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 30948273
Scopus: 2-s2.0-85064822007
Source Identifiers
ISSN: 1470-2045
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service